ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

SBTX Skinbiotherapeutics Plc

9.25
0.11 (1.20%)
01 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.11 1.20% 9.25 9.00 9.50 9.25 9.25 9.25 1,064,455 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -5.67 16.1M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 9.14p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £16.10 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -5.67.

Skinbiotherapeutics Share Discussion Threads

Showing 8551 to 8569 of 23525 messages
Chat Pages: Latest  353  352  351  350  349  348  347  346  345  344  343  342  Older
DateSubjectAuthorDiscuss
17/1/2021
22:43
Remarkably quiet here especially after the posts inside the guild BB. Is everyone holding their cards to their chests? lol
slartybartfaster
16/1/2021
16:04
I liked the idea of the food supplement for acne currently being worked on to be potentially incorporated into chewing gum. Also of interest was that for cleanbiotix was talking to two interested parties in the Hospital and Cleaning sector and that has now gone up to six as a result of increased interest post Covid
aquaesulis01
16/1/2021
13:37
Impressive numbers coming out of the company. Not much if anything new in the TW/SA interview. Nice to see Elrics numbers confirmed. It may have more credibility through share price subscription base because of the numbers subscribed.
slartybartfaster
16/1/2021
13:28
Hello Dave, how is Icon and Syme doing?
professor_kemche
15/1/2021
23:48
i do not feel respected. Bye
sentiment riles
15/1/2021
23:41
hello knut

Thank you

sentiment riles
15/1/2021
16:20
mad, many thanks for the response, have just added to my already substantial holding.
aquaesulis01
15/1/2021
15:40
Well there couldn't be anything materially new in the TW interview, because if there was he couldn't hide it behind a paywall surely?
nik7907
15/1/2021
15:36
It looks like TW has influenced a 25k block seller. Lol.
slartybartfaster
15/1/2021
15:36
Thought you wasn't paying to listen Slarty ?
scotty1
15/1/2021
15:25
There's nothing new in the SA TW interview.
slartybartfaster
15/1/2021
13:42
Aqua, this response to the email question from SA. "We are extremely confident that we will fill the 200 places for the study. We have had a very positive response thus far and it's only a couple of days since we posted the RNS. In the meantime our PR people are pushing the release out to the specialist dermatology media and the wider world. With regards to the UK psoriasis association, they never use their platform or membership for market research, regardless of the company. Unlike the US Psoriasis foundation. That said, many of the study applicants so far are members of said. We will report the study findings back to the UK Association in due course. I am delighted with the progress we have made this week. Watch this space!"
madaboutmed
15/1/2021
10:59
Financial Times?
Oh

Is that where the rest learned then?

looooooooooooool

sentiment riles
15/1/2021
10:58
The financial Times are you frigging joking!
christopher logsdon
15/1/2021
10:56
I think they call that a blow job interview
christopher logsdon
15/1/2021
10:27
get th3e Financial Times to ask the question

Tend to get faster replies that way when/if they do it for you

sentiment riles
15/1/2021
10:26
I will email him and see if we get a response. He usually does within a day or two. I would imagine he is quite busy with all of this at the moment.
madaboutmed
15/1/2021
10:08
mad, the question I would like answered concerns the confidence SA has that he will get sufficient applicants for a meaningful trial; will most volunteers be recruited via the psoriasis associations rather than relying on word of mouth for potential volunteers to find out about this trial?
The reason I ask is that the synairgem home trial for SNG001 has taken an age to recruit volunteers by their passive website approach for their covid19 treatment so would hate skinbio to suffer the same fate.

It would be good to get the axisbio link on the psoriasis association website

hxxps://www.psoriasis-association.org.uk/news/

aquaesulis01
15/1/2021
09:36
atlantic i think the TW interview will be a bit more searching and longer.
scotty1
Chat Pages: Latest  353  352  351  350  349  348  347  346  345  344  343  342  Older

Your Recent History

Delayed Upgrade Clock